Normally, in this part of Uganda, medication is delivered by boat—a slow, difficult process. But now a new Johnson & Johnson-supported program is using drones that can serve 20 landing sites across five islands, reaching more than 3,700 people in a single day.
Johnson & Johnson's 2020 Health for Humanity Report details the progress it's made in the past five years in driving sustainable social, environmental and economic change around the globe. Now the company's looking ahead to the next five.
Despite being preventable and curable, tuberculosis is one of the world’s deadliest infectious diseases—and COVID-19 is making it even harder to diagnose and treat it. Enter these healthcare visionaries, who've made it their mission to move the world closer to the goal of ending tuberculosis.
Two experts in the field share the latest understanding and research into conditions like pediatric plaque psoriasis, juvenile idiopathic arthritis and pediatric active psoriatic arthritis—diseases that afflict children and can have long-term damaging effects into adulthood if not properly treated.
Will Song's teams were on the front lines when COVID-19 shut down the city of Wuhan. One year to the day that the World Health Organization declared the disease a pandemic,he shares how the company kept going during the crisis and the innovative ideas that emerged from it.
Learn more about the event, Johnson & Johnson's historic collaboration with Merck—and watch a video that chronicles the progress that the company has made since last March in the fight against COVID-19.
We're spotlighting three of the company's pioneering early female scientists—and their modern-day counterparts, who are not only innovating in the lab, but also paving the way for the next generation of powerhouse women.
As the U.S. government announces an agreement between Johnson & Johnson and Merck to collaborate on vaccine production,we trace all the steps it takes—from growing cells in a bioreactor to prepping palettes with high-tech track-and-trace technology—to develop and manufacture a vaccine during a pandemic.
Imagine having a disease that many doctors have never seen before. That's what Marty Verel experienced when he was told he had AL amyloidosis—and it's what hematologist Brendan Weiss, M.D., is determined to help change. For Amyloidosis Awareness Month, Dr. Weiss shares what he's learned studying the rare disease.